A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial

Psychedelics and Other Psychoplastogens for Treating Mental Illness

(2021) Maxemiliano V. Vargas et al.   Frontiers in Psychiatry

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

(2020) Chadi G. Abdallah et al.   NEUROPSYCHOPHARMACOLOGY

Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial

(2020) Eric J. Lenze et al.   AMERICAN JOURNAL OF PSYCHIATRY

Memantine effects on auditory discrimination and training in schizophrenia patients

(2020) Neal R. Swerdlow et al.   NEUROPSYCHOPHARMACOLOGY

Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder

(2019) Margaret M. McClure et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial

(2019) Elias Dakwar et al.   AMERICAN JOURNAL OF PSYCHIATRY

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

(2019) Elias Dakwar et al.   AMERICAN JOURNAL OF PSYCHIATRY

Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model

(2019) Rebecca B. Price et al.   MOLECULAR PSYCHIATRY

Leveraging neuroplasticity to enhance adaptive learning: The potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression

(2018) Samuel T. Wilkinson et al.   BIOLOGICAL PSYCHIATRY

124. Experimental Medicine Approaches to Leveraging Auditory Information Processing Neuroplasticity Toward Therapeutic Development in Schizophrenia

(2017) Neal Swerdlow et al.   SCHIZOPHRENIA BULLETIN

Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia

(2017) Philip D. Harvey et al.   Frontiers in Psychiatry

Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness

(2016) Marloes J. Huijbers et al.   JOURNAL OF AFFECTIVE DISORDERS

Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis

(2016) Jeffrey N. Motter et al.   JOURNAL OF AFFECTIVE DISORDERS

Ketamine steps out of the darkness

(2016) Roberto Malinow   NATURE

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

(2016) Ronald S Duman et al.   NATURE MEDICINE

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

(2015) D. Jeffrey Newport et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

(2015) Chadi G. Abdallah et al.   Annual Review of Medicine

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

(2015) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Single-Dose Ketamine Followed by Daily d-Cycloserine in Treatment-Resistant Bipolar Depression

(2015) Joshua T. Kantrowitz et al.   JOURNAL OF CLINICAL PSYCHIATRY

Computerized Cognitive Behavior Therapy for Anxiety and Depression in Rural Areas: A Systematic Review

(2015) Kari Dee Vallury et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder

(2015) J W Murrough et al.   Translational Psychiatry

A Word to the Wise About Ketamine

(2014) Alan F. Schatzberg   AMERICAN JOURNAL OF PSYCHIATRY

EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION

(2014) Rebecca B. Price et al.   DEPRESSION AND ANXIETY

Multistage drug effects of ketamine in the treatment of major depression

(2014) Martin Walter et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Behavioral Intervention Technologies: Evidence review and recommendations for future research in mental health

(2013) David C. Mohr et al.   GENERAL HOSPITAL PSYCHIATRY

PATIENT TREATMENT PREFERENCE AS A PREDICTOR OF RESPONSE AND ATTRITION IN TREATMENT FOR CHRONIC DEPRESSION

(2012) Dana Steidtmann et al.   DEPRESSION AND ANXIETY

Increasing body satisfaction of body concerned women through evaluative conditioning using social stimuli.

(2010) Carolien Martijn et al.   HEALTH PSYCHOLOGY

Evaluative conditioning in humans: A meta-analysis.

(2010) Wilhelm Hofmann et al.   PSYCHOLOGICAL BULLETIN

Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression

(2009) Rebecca B. Price et al.   BIOLOGICAL PSYCHIATRY

RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)

(2009) Gregory M. Chandler et al.   CNS Neuroscience & Therapeutics